Clinical Trial Update: Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX® [Phase 4]

View source ↗

Summary

A Phase 4 open-label trial evaluating long-term treatment of moderate to severe glabellar lines with CORETOX.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• CORETOX

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 4 | Status: UNKNOWN